PharmaShots Weekly Snapshots (April 08 – April 12, 2024)

Share this

PharmaShots Weekly Snapshots (April 08 – April 12, 2024)

This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:


Eli Lilly and Boehringer Ingelheim Reveal Results from the P-III (EMPACT-MI) Study of Jardiance to Prevent the Risk of Heart Failure and Death Post Heart Attack

Read More: Eli Lilly & Boehringer Ingelheim                                                        

Novartis Reveals the P-IIIb (V-INITIATE) Trial Results of Leqvio for Treating Atherosclerotic Cardiovascular Disease (ASCVD)

Read More: Novartis                                                                                                 

BMS Reveals Pooled Interim Results from a Series of P-III (EMERGENT) Studies Evaluating KarXT for Schizophrenia at the SIRS 2024

Read More: BMS                                                                                                       

BMS Features the P-I/II Study Results of Krazati in Addition with Cetuximab for the Treatment of Locally Advanced or Metastatic Colorectal Cancer at the AACR 2024

Read More: BMS                                                                                                   

Pfizer Reveals the P-III Study Data of Abrysvo for Increased Risk for RSV Disease

Read More: Pfizer                                                                                    

Rapt Therapeutics Highlights Results from the P-II Study of Tivumecirnon in Combination with Keytruda for Treating Head and Neck Cancer 

Read More: Rapt Therapeutics                                                                     

Monopar Therapeutics Commences the P-I Trial of MNPR-101-Zr for Treating Advanced Cancer

Read More: Monopar Therapeutics                                                                     

Teva Reports the P-III Study Data of Ajovy (fremanezumab) to Prevent Migraine in Chinese Patients

Read More: Teva                                                                                                  

Boundless Bio Reports First Patient Dosing with BBI-825 in the P-I/II Study for Cancer Treatment

Read More: Boundless Bio                                                                                       

Enliven Therapeutics Reveals the PoC Results from the P-I Clinical Evaluation of ELVN-001 for the Treatment of Chronic Myeloid Leukemia

Read More: Enliven Therapeutics                                                                     


AstraZeneca and Daiichi Sankyo’s Enhertu Gains the US FDA’s Accelerated Approval to Treat Metastatic HER2-Positive Solid Tumors

Read More: AstraZeneca & Daiichi                                                                      

The US FDA Grants FTD to PureTech’s LYT-200 for the Treatment of Head and Neck Cancers

Read More: PureTech                                                                                           

Candel Therapeutics’ CAN-2409 Obtains the US FDA’s Orphan Drug Designation to Treat Pancreatic Cancer

Read More: Candel Therapeutics                                                                          


Boston Scientific Reports the Commencement of NAVIGATE-PF Study Evaluating Farawave Nav Pulsed Field Ablation Catheter and Faraview Software Module

Read More: Boston Scientific                                                                                   

HeartBeam Highligts Data from the Study of Using Artificial Intelligence for Detecting Arrhythmias 

Read More: HeartBeam                                                                                       

Roche’s Ventana HER2 (4B5) Test Gains CE Mark for HER2-Low Metastatic Breast Cancer

Read More: Roche                                                                                            

The US FDA Grants Breakthrough Device Designation to Roche’s Elecsys pTau217 Assay for Diagnosing Alzheimer's Disease

Read More: Roche                                                                                          

The US FDA Grants Breakthrough Device Designation to Simpson Interventions’ Acolyte Image Guided Crossing and Re-Entry Catheter System

Read More: Simpson                 


Henlius and Organon Reveal Results from the P-III Study of HLX14, Biosimilar Candidate of Denosumab

Read More: Henlius & Organon                                                                                


Coherus BioSciences Highlights the Preclinical Data of CHS-1000 for Solid Tumors at the AACR 2024

Read More: Coherus BioSciences                                                                            

Merus Features the Zenocutuzumab’s Preclinical Results for Cancer Treatment at the AACR 2024

Read More: Merus                                                                                                     


Nucleai and GoPath Diagnostics Collaborate on AI-Based Digital Pathology Solutions for Clinical Research and Diagnosis

Read More: Nucleai & GoPath Diagnostics                                                       

Transcenta Collaborates with Agilent Technologies on Claudin18.2 Companion Diagnostic to Support the P-III Study of Osemitamab

Read More: Transcenta & Agilent Technologies                                       

Bayer Partners with Google Cloud on AI-Based Solutions for Radiologists

Read More: Bayer & Google Cloud                                                           


Merck Animal Health Launches Flocksecure Poultry Health Portal

Read More: Merck Animal Health                                                                


NeuroSense and Lonza Join Forces on Exosome-based Biomarkers for the Diagnosis and Treatment of Neurodegenerative Disease 

Read More: NeuroSense & Lonzav                                                                 

Rallybio and Johnson & Johnson Collaborate to Develop Therapies for Preventing Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Read More: Rallybio & Johnson & Johnson                                                          

Arvinas and Novartis Join Forces to Develop and Commercialize ARV-766 for Treating Prostate Cancer

Read More: Arvinas & Novartis                                                                                 

Harmony Biosciences and Bioprojet Join Forces to Develop TPM-1116 for Treating Narcolepsy and Other Sleep/Wake Disorders

Read More: Harmony Biosciences & Bioprojet                           


For an Aggregate of ~$4.9B, Vertex to Acquire Alpine Immune Sciences

Read More: Vertex & Alpine Immune Sciences                                                   

Related Post:- PharmaShots Weekly Snapshots (April 01 – April 05, 2024)

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions